AEON Biopharma (AEON) Institutional Ownership $0.78 -0.02 (-2.50%) Closing price 08/14/2025 03:59 PM EasternExtended Trading$0.75 -0.03 (-3.33%) As of 04:33 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for AEON Biopharma (NASDAQ:AEON)CurrentInstitutional OwnershipPercentage22.78%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$23.03MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$82.13M Get AEON Insider Trade Alerts Want to know when executives and insiders are buying or selling AEON Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AEON Institutional Buying and Selling by Quarter AEON Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/7/2025Dauntless Investment Group LLC1,025,000$594K0.7%N/A9.731% 2/25/2025Polar Asset Management Partners Inc.2,762,688$1.49M0.0%-23.3%3.455% 2/19/2025 Formidable Asset Management LLC689,182$372K0.1%+76.8%0.862% 2/17/2025Polar Asset Management Partners Inc.2,762,688$1.49M0.0%-23.3%3.455% 2/14/2025 Blue Owl Capital Holdings LP3,049,361$1.65M0.4%-8.7%3.813% 11/16/2024 Geode Capital Management LLC243,168$255K0.0%+30.1%0.622% 11/15/2024Polar Asset Management Partners Inc.3,599,918$3.78M0.1%-2.0%9.202% 11/15/2024 HighTower Advisors LLC23,776$25K0.0%N/A0.061% 11/7/2024Caprock Group LLC62,686$66K0.0%N/A0.160% 8/14/2024Davidson Kempner Capital Management LP90,053$95K0.0%-75.4%0.230% 5/17/2024Shaolin Capital Management LLC21,380$248K0.0%-97.7%0.057% 5/10/2024 Vanguard Group Inc.758,992$8.80M0.0%+261.8%2.008% 2/7/2024 Formidable Asset Management LLC58,193$419K0.1%-9.5%0.157% 11/9/2023 Formidable Asset Management LLC64,311$360K0.1%N/A0.723% 11/6/2023Atalaya Capital Management LP3,675,000$19.83M21.7%N/A41.283% (Data available from 1/1/2016 forward) AEON Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AEON shares? During the previous two years, 11 institutional investors and hedge funds held shares of AEON Biopharma. The most heavily invested institutionals were Atalaya Capital Management LP ($19.83M), Vanguard Group Inc. ($8.80M), Blue Owl Capital Holdings LP ($1.65M), Polar Asset Management Partners Inc. ($1.49M), Dauntless Investment Group LLC ($594K), Formidable Asset Management LLC ($372K), and Geode Capital Management LLC ($255K).Learn more on AEON Biopharma's institutional investors. What percentage of AEON Biopharma's stock is owned by institutional investors? 22.78% of AEON Biopharma's stock is owned by institutional investors. Learn more on AEON's institutional investor holdings. Which institutional investors have been buying AEON Biopharma's stock? The following institutional investors have purchased AEON Biopharma's stock in the last 24 months: Atalaya Capital Management LP ($3.68M), Dauntless Investment Group LLC ($1.03M), Vanguard Group Inc. ($549.21K), Formidable Asset Management LLC ($363.71K), Caprock Group LLC ($62.69K), Geode Capital Management LLC ($56.31K), and HighTower Advisors LLC ($23.78K). How much institutional buying is happening at AEON Biopharma? Institutional investors have bought a total of 1,467,172 shares in the last 24 months. This purchase volume represents approximately $23.03M in transactions. Which of AEON Biopharma's major shareholders have been selling company stock? The following institutional investors have sold AEON Biopharma stock in the last 24 months: Polar Asset Management Partners Inc. ($1.75M), and Blue Owl Capital Holdings LP ($291.84K). How much institutional selling is happening at AEON Biopharma? Institutional investors have sold a total of 2,041,385 shares in the last 24 months. This volume of shares sold represents approximately $82.13M in transactions. Related Companies AKTX Major Shareholders ESLA Major Shareholders SNYR Major Shareholders ITRM Major Shareholders DYAI Major Shareholders CLSD Major Shareholders OKUR Major Shareholders KZR Major Shareholders CLNN Major Shareholders GBIO Major Shareholders This page (NASDAQ:AEON) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access